How big is The Ensign Group, Inc.?

As of Jun 18, The Ensign Group, Inc. has a market capitalization of $9.28 billion, with net sales of $4.42 billion and a net profit of $309.85 million for the latest four quarters. The balance sheet as of Dec'24 shows shareholder's funds of $1.84 billion and total assets of $5.20 billion.

As of Jun 18, The Ensign Group, Inc. has a market capitalization of 9,277.82 million, categorizing it as a Mid Cap company.<BR><BR>As of Jun 18, the company reported net sales of 4,423.36 million and a net profit of 309.85 million for the latest four quarters ending in Mar'25, Dec'24, Sep'24, and Jun'24.<BR><BR>As of Dec'24, the balance sheet shows shareholder's funds of 1,837.11 million and total assets of 5,202.15 million.

What does The Ensign Group, Inc. do?

The Ensign Group, Inc. specializes in healthcare services, focusing on skilled nursing and rehabilitative services. As of March 2025, it reported net sales of $1.173 billion and a net profit of $80 million, with a market cap of approximately $9.28 billion.

Overview:<BR>The Ensign Group, Inc. provides healthcare services, specializing in skilled nursing and rehabilitative services within the Pharmaceuticals & Biotechnology industry, and operates in the mid-cap market segment.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 1,173 Million (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: 80 Million (Quarterly Results - Mar 2025) <BR>Market-cap: USD 9,277.82 Million (Mid Cap)<BR><BR>Key Metrics:<BR>P/E: 30.00 <BR>Dividend Yield: 0.15% <BR>Debt Equity: -0.05 <BR>Return on Equity: 16.14% <BR>Price to Book: 4.82<BR><BR>Contact Details:<BR>Address: 29222 Rancho Viejo Rd Ste 127, SAN JUAN CAPISTRANO CA: 92675-1049 <BR>Tel: 1 949 4879500 <BR>Website: https://ensigngroup.net/

Should I buy, sell or hold The Ensign Group, Inc.?

Who are in the management team of The Ensign Group, Inc.?

As of March 2022, The Ensign Group, Inc.'s management team includes Co-Founder and Executive Chairman Christopher Christensen, CEO Barry Port, and several independent directors: Swati Abbott, Ann Blouin, Lee Daniels, and Daren Shaw. Roy Christensen serves as Chairman Emeritus.

As of March 2022, the management team of The Ensign Group, Inc. includes the following individuals:<BR><BR>- Mr. Christopher Christensen: Co-Founder, Executive Chairman, and the Chairman of the Board<BR>- Mr. Roy Christensen: Chairman Emeritus<BR>- Mr. Barry Port: Chief Executive Officer and Director<BR>- Ms. Swati Abbott: Independent Director<BR>- Dr. Ann Blouin: Independent Director<BR>- Mr. Lee Daniels: Independent Director<BR>- Mr. Daren Shaw: Independent Director<BR><BR>This team plays a crucial role in guiding the company's strategic direction and operations.

Is The Ensign Group, Inc. technically bullish or bearish?

As of August 5, 2025, The Ensign Group, Inc. shows a bullish trend supported by strong technical indicators, outperforming the S&P 500 with a year-to-date return of 25.75%, despite some mixed signals in longer-term indicators.

As of 5 August 2025, the technical trend has changed from mildly bullish to bullish. The current stance is bullish with strong indicators supporting this view, including bullish MACD readings on both the weekly and monthly time frames, and a bullish daily moving average. The Bollinger Bands are showing a mildly bullish trend on both weekly and monthly charts. However, the KST is bullish weekly but mildly bearish monthly, and Dow Theory indicates a mildly bearish weekly stance while remaining bullish monthly. <BR><BR>In terms of performance, The Ensign Group, Inc. has outperformed the S&P 500 year-to-date with a return of 25.75% compared to the S&P's 12.22%, and over three years, it has returned 97.09% versus the S&P's 70.41%. Overall, the technical indicators suggest a strong bullish sentiment despite some mixed signals in the longer-term indicators.

Is The Ensign Group, Inc. overvalued or undervalued?

As of October 17, 2025, The Ensign Group, Inc. is considered undervalued with an attractive valuation grade, featuring a P/E ratio of 30, an EV to EBITDA of 19.44, and a PEG ratio of 0.36, indicating potential growth compared to peers like Encompass Health Corp. and DaVita, Inc.

As of 17 October 2025, The Ensign Group, Inc. has moved from a very expensive valuation grade to attractive. Based on the current metrics, the company appears to be undervalued. Key valuation ratios include a P/E ratio of 30, an EV to EBITDA of 19.44, and a PEG ratio of 0.36, which suggests that the stock may offer growth potential relative to its price.<BR><BR>In comparison to peers, The Ensign Group's P/E ratio of 30 is higher than Encompass Health Corp.'s 20.94, but lower than its own previous valuation. The EV to EBITDA ratio of 19.44 is also more favorable than the risky DaVita, Inc.'s 7.56, indicating a stronger operational performance. Although return data is not available for a direct comparison with the S&P 500, the recent grade change and attractive valuation suggest a positive outlook for the stock.